Valerio Therapeutics Announces Board Members and Their Roles

Valerio Therapeutics, a public company based in Paris, revealed its list of board members and their roles in other companies as of March 19, 2025. Julien Miara, the Chief Executive Officer, serves as Managing Director at Invus and holds director positions at Sensorion and Versity. Jacques Mallet, Chairman of the Board, is involved with Gamma-X Corporate Advisory, Technoflex, and the Fournier Majoie Foundation.

The board also includes representatives from Financière de la Montagne, directed by Nicolas Trebouta. This entity manages several roles, including chairing SAS Dragon 8 and the Supervisory Board of SCA Chevrillon & Associés. Bryan Giraudo, a Director, operates as COO and CFO at Gossamer Bio Inc and holds a director role at Protagonist Therapeutics.

Antoine Barouky, COO, is the Chairman & CEO of both MAAsiRNA and AB Global Strategy. Shefali Agarwal, another Director, serves on the boards of ITB Med, Gritstone Bio, and Fate Therapeutics, among others.